| Prev Close | 18.62 |
| Day Low/High | 18.30 / 19.84 |
| 52 Wk Low/High | 8.50 / 25.46 |
Omeros Corporation (OMER)
19.67
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 61.65B |
| Market Cap | 1.15B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Year-End Good Tidings for 2 Promising Biotechs
Omeros Corp. and Eyenovia Inc. were the recipients of positive news this week.
2 Biotech Stocks to Consider in an Overvalued Market
I think the market is getting at least a little ahead of itself.
Matching Downside Protection With Upside Potential in Akebia Therapeutics
This covered call strategy is an effective way to navigate an overbought market.
A Trio of Back-to-Normality Trades Worth Noting
With lockdowns ending and life as we knew it resuming to some extent, these three stocks should benefit.
2 Small Biotechs Face Crossroads Years in 2020
Dynavax Technologies and Omeros Corp. have tested shareholders' patience over time and again are at inflection points.
3 Small-Cap Biotech Stocks That Could Thrive in 2020
The trio of BioDelivery Sciences, Omeros and TG Therapeutics looks well-positioned to capitalize on their potential in the New Year.
2 Small-Cap Biotech Stocks I Continue to Like
Both these names reported third-quarter results last week.
2 Candidates That Could Be the Next Biotech Rockets
Omeros Corp. and EyePoint Pharmaceuticals each have promising treatments that could send their shares skyward.
Here Are Several Promising Rare Disease Stocks
These small biotech concerns are undervalued.
Why 3 Biotechs Are Rallying Today
It's a decent start to the trading day as all the major indices are slightly in the green. We are seeing a lot of small biotech stocks I have profiled in these pages rallying on news. Let's start with T2 Biosystems . It is up 25% today as it was awa...
A Trio of Small Biotech Companies Garnering Attention
The three either have made recent progress toward advancing products in their pipelines or have caught the eye of analysts.
A Closing Comment on a Biotech Mover
As always it was good to sit in for Doug Kass over the past two trading sessions. Equities lost some traction toward the end of the day. The Dow and S&P 500 closed with OK gains while the NASDAQ was down slightly. Biotech was not the place to be tod...
Names to Watch Amid Biotech's Nascent Rally
Progenics and Tesaro are among sagging small-cap biotech stocks that could rebound in coming months.
2 Small Biotechs That Continue to Look Good
Several biotech names held up well or even had solid advances during last week's broad market selloff.
2 Small Biotechs That Look Good
Achaogen and Omeros both rose as the Dow was losing 724 points.
Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers
The South San Francisco, Calif.-based firm said after the market close on Tuesday that the FDA has extended the review period for the company's prior approval supplement for Bevyxxa (betrixaban).
5 Small Biotechs Receive Shots in the Arm
Favorable quarterly results and FDA drug approvals should help lift these five names.
5 Small Biotechs Receive Shots in the Arm
Favorable quarterly results and FDA drug approvals should help lift these five names.
Housing Stocks Will See Demand Boost
The housing market will continue to improve over the next few years due to pent up demand.
Don't Panic About Biotech
Diversification is absolutely critical when investing in this sector.
3 Housing Plays With Solid Earnings
These names are building a sound foundation for growth.
These 3 Small Biotechs Have a Healthy Shot
Several firms hiked price targets on Portola into the $70s this week.
Give These 3 Small Biotechs a Shot
Several firms hiked price targets on Portola into the $70s this week.
Biotech Stocks Finally Stage Breakthrough
The sector decisively has pushed through upward resistance levels in place for many months.
Cruising Through the Grocery and Biotech Aisles
Looks like the grocery sector is going to be a theme for this Friday. In the story of the day, and maybe of the week, Amazon has announced it will buy organic food pioneer Whole Foods for $42 a share in an all-cash transaction. Walmart is down 5% i...
3 Small Biotech Value Plays
These stocks will be great stories in the second half of 2017, and are significantly undervalued.
The Dip Buyers Aren't Delivering Much Right Now
The indices are holding key support, but this isn't translating into any real momentum.
3 Small Biotechs That Still Have Upside
Companies developing drugs for cancer, eye problems and pets -- offer untapped value.
Oil, Equity Indices Higher
The market has strengthened considerably since our last update, with all the major indices sporting solid gains across the board. Oil is also up 1% on the day. Restaurant stocks are having a good day after solid earnings reports from Yum Brands and...
Scanning the Biotech Universe
Markets are slightly down in the early going. Gilead Science GILD is off about 9% on dismal revenue guidance for 2017 and price target downward revisions at various analyst firms. If 2017 projections do not light a fire under company to use mergers ...
